Company Filing History:
Years Active: 2022
Title: Innovations by Ashley Mahne in Autoimmune Disease Treatment
Introduction
Ashley Mahne is an accomplished inventor based in San Francisco, CA. She has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. Her innovative approach focuses on utilizing FOXP3+CD4+ T cells to develop effective therapies.
Latest Patents
Ashley Mahne holds a patent for a method related to treating diseases using FOXP3+CD4+ T cells. This patent outlines methods and materials for treating mammals with autoimmune diseases. Specifically, it provides insights into producing T cells that comprise a FOXP3 polypeptide and one or more transcription factors. The patent also details methods for administering an effective amount of these T cells to mammals suffering from autoimmune conditions.
Career Highlights
Ashley is currently associated with Kyverna Therapeutics, Inc., where she continues to advance her research and innovations. Her work is pivotal in developing new therapeutic strategies that can significantly improve the quality of life for individuals with autoimmune diseases.
Collaborations
Ashley collaborates with notable colleagues, including John Lee and Lih-Yun Hsu, who contribute to her research efforts and innovations in the field.
Conclusion
Ashley Mahne's work exemplifies the impact of innovative thinking in medicine, particularly in the treatment of autoimmune diseases. Her contributions through her patent and ongoing research at Kyverna Therapeutics, Inc. highlight the importance of advancements in this critical area of healthcare.